tm logo
AMPCASUS
Live/Pending
FOURTH EXTENSION - GRANTED

granted

on 29 Oct 2024

Last Applicant/ Owned by

86 Morris Avenue

Summit

NJ

07901

Serial Number

90860796 filed on 02th Aug 2021

Registration Number

N/A

Correspondent Address

Xiomara Triana

Xiomara Triana BRISTOL-MYERS SQUIBB COMPANY

TRADEMARKS DEPT., MAILSTOP D4243

PRINCETON, NJ 08648-4000

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

AMPCASUS

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprol Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical and biological preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders, and monoclonal antibodies for medical use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 90860796

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 00160173-US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
29th Oct 2024SOU EXTENSION 4 GRANTED
29th Oct 2024SOU EXTENSION 4 FILED
29th Oct 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29th Oct 2024SOU TEAS EXTENSION RECEIVED
06th Apr 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05th Apr 2024SOU TEAS EXTENSION RECEIVED
05th Apr 2024SOU EXTENSION 3 GRANTED
05th Apr 2024SOU EXTENSION 3 FILED
14th Oct 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12th Oct 2023SOU EXTENSION 2 GRANTED